$CSR
Centerspace Stock $csr

$csr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000079835924000019 Filed on February 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$64.51M	$64.07M	$261.3M
YoY Change	-4.99%	-5.57%	1.79%
Cost Of Revenue	$26.66M	$26.54M	$9.353M
YoY Change	938.2%	-15.95%	-5.48%
Gross Profit	$37.85M	$37.53M	$252.0M
YoY Change	-42.07%	3.47%	2.08%
Gross Profit Margin	58.67%	58.58%	96.42%
Selling, General & Admin	$5.324M	$5.238M	$19.70M
YoY Change	-31.06%	59.89%	12.49%
% of Gross Profit	14.07%	13.96%	7.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$27.31M	$26.91M	$103.2M
YoY Change	2.46%	3.08%	-2.86%
% of Gross Profit	72.15%	71.7%	40.95%
Operating Expenses	$32.34M	$31.85M	$121.4M
YoY Change	-4.09%	9.68%	-1.13%
Operating Profit	$5.509M	$5.674M	$84.45M
YoY Change	-91.2%	-21.49%	509.29%
Interest Expense	-$8.867M	-$8.380M	$36.43M
YoY Change	-185.93%	-11.52%	11.23%
% of Operating Profit	-160.95%	-147.69%	43.14%
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.792M	-$9.885M	$49.23M
YoY Change	-109.16%	285.38%	-379.07%
Income Tax
% Of Pretax Income
Net Earnings	-$5.512M	-$9.764M	$41.33M
YoY Change	-112.65%	170.25%	-392.9%
Net Earnings / Revenue	-8.54%	-15.24%	15.81%
Basic Earnings Per Share	-$0.37		$2.33
Diluted Earnings Per Share	-$0.37	-$0.65	$2.32
COMMON SHARES
Basic Shares Outstanding	14.91M shares	15.05M shares	14.99M shares
Diluted Shares Outstanding	14.92M shares		17.12M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.68M	$8.630M	$8.630M
YoY Change	41.87%	-17.48%	-17.48%
Cash & Equivalents	$12.68M	$8.630M	$8.630M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables			$614.0K
Other Receivables			$0.00
Total Short-Term Assets	$12.68M	$8.630M	$9.244M
YoY Change	41.87%	-17.48%	-53.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.860B	$2.798M	$1.892B
YoY Change	-2.18%	-10.32%	-5.48%
Goodwill		$491.0K
YoY Change		-43.3%
Intangibles		$2.723M
YoY Change		28.93%
Long-Term Investments
YoY Change
Other Assets	$1.066M	$639.0K	$9.329M
YoY Change	-97.82%	-55.41%	221.25%
Total Long-Term Assets	$1.891B	$1.918B	$1.917B
YoY Change	-4.02%	-5.2%	-4.79%
TOTAL ASSETS
Total Short-Term Assets	$12.68M	$8.630M	$9.244M
Total Long-Term Assets	$1.891B	$1.918B	$1.917B
Total Assets	$1.903B	$1.926B	$1.926B
YoY Change	-3.81%	-5.26%	-5.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$54.61M	$62.75M	$62.75M
YoY Change	-3.58%	6.7%	6.7%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.61M	$62.75M	$62.75M
YoY Change	-3.58%	6.7%	6.7%
LONG-TERM LIABILITIES
Long-Term Debt	$925.2M	$916.0M	$916.0M
YoY Change	0.8%	-9.09%	-9.09%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$925.2M	$916.0M	$916.0M
YoY Change	0.8%	-9.09%	-9.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.61M	$62.75M	$62.75M
Total Long-Term Liabilities	$925.2M	$916.0M	$916.0M
Total Liabilities	$1.199B	$978.8M	$1.200B
YoY Change	23.01%	-8.22%	-6.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$565.0M	-$548.3M
YoY Change	11.12%	1.64%
Common Stock	$1.160B	$1.166B
YoY Change	-1.32%	-1.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$704.7M	$709.8M	$726.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.903B	$1.926B	$1.926B
YoY Change	-3.81%	-5.26%	-5.26%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$5.512M	-$9.764M	$41.33M
YoY Change	-112.65%	170.25%	-392.9%
Depreciation, Depletion And Amortization	$27.31M	$26.91M	$103.2M
YoY Change	2.46%	3.08%	-2.86%
Cash From Operating Activities	$24.40M	$12.10M	$89.52M
YoY Change	11.92%	-47.43%	-2.69%
INVESTING ACTIVITIES
Capital Expenditures	$21.81M	$61.65M	$101.1M
YoY Change	94.09%	167.28%	-37.37%
Acquisitions
YoY Change
Other Investing Activities	$12.78M	-$3.515M	$420.0K
YoY Change	-1632.13%	-3266.67%	-134.4%
Cash From Investing Activities	-$9.032M	-$65.16M	$120.2M
YoY Change	-106.88%	183.88%	-175.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$11.54M
YoY Change			-584.83%
Debt Paid & Issued, Net	$1.529M		$46.75M
YoY Change	-92.63%		61.43%
Cash From Financing Activities	-10.89M	10.13M	-$212.4M
YoY Change	-89.82%	-322.87%	-613.31%
NET CHANGE
Cash From Operating Activities	24.40M	12.10M	$89.52M
Cash From Investing Activities	-9.032M	-65.16M	$120.2M
Cash From Financing Activities	-10.89M	10.13M	-$212.4M
Net Change In Cash	4.479M	-42.93M	-$2.622M
YoY Change	-90.25%	857.57%	-90.19%
FREE CASH FLOW
Cash From Operating Activities	$24.40M	$12.10M	$89.52M
Capital Expenditures	$21.81M	$61.65M	$101.1M
Free Cash Flow	$2.593M	-$49.55M	-$11.53M
YoY Change	-75.46%	105319.15%	-83.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Profit Loss ProfitLoss	49231000	usd
CY2023	csr	Preferred Stock Dividends PreferredStockDividends	640000	usd
CY2022	csr	Preferred Stock Dividends PreferredStockDividends	640000	usd
CY2023	csr	Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable	7141000	usd
CY2022	csr	Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable	-4299000	usd
CY2021	csr	Noncontrolling Interest In Net Income Loss Operating Partnerships And Preferred Unit Holders Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsAndPreferredUnitHoldersNonredeemable	-2806000	usd
CY2021	csr	Fair Value Adjustment Debt FairValueAdjustmentDebt	2367000	usd
CY2022	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	127000	usd
CY2021	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	94000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14109000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-29000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	49231000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-17641000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2101000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	43276000	usd
CY2023	csr	Noncash Or Part Noncash Acquisition Write Off Of Receivable In Exchange For Property NoncashOrPartNoncashAcquisitionWriteOffOfReceivableInExchangeForProperty	0	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000798359
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Fair Value Asset Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://centerspacehomes.com/20231231#InterestAndOtherIncomeLoss
CY2023	us-gaap	Fair Value Asset Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://centerspacehomes.com/20231231#InterestAndOtherIncomeLoss
CY2023	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#GainLossOnSaleOfInvestments
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	csr	Number Of Consecutive Trading Days For Valuation NumberOfConsecutiveTradingDaysForValuation	P10D
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35624
CY2023	dei	Entity Registrant Name EntityRegistrantName	CENTERSPACE
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	ND
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-0311232
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3100 10th Street SW
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Post Office Box 1988
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Minot
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	ND
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	58702-1988
CY2023	dei	City Area Code CityAreaCode	701
CY2023	dei	Local Phone Number LocalPhoneNumber	837-4738
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	913064559	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14908674	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2420146000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2534124000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	530703000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	535401000	usd
CY2023Q4	us-gaap	Investments Investments	1889443000	usd
CY2022Q4	us-gaap	Investments Investments	1998723000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8630000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10458000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	639000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1433000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	27649000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	22687000	usd
CY2023Q4	us-gaap	Assets Assets	1926361000	usd
CY2022Q4	us-gaap	Assets Assets	2033301000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	62754000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	58812000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	30000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	113500000	usd
CY2023Q4	us-gaap	Unsecured Debt UnsecuredDebt	299459000	usd
CY2022Q4	us-gaap	Unsecured Debt UnsecuredDebt	399007000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	586563000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	495126000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	978776000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1066445000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	166000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	166000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	166000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	166000	shares
CY2022Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	16560000	usd
CY2023Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	16560000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	16560000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	16560000	usd
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3881000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3881000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3881000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3881000	shares
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	97036000	usd
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	97036000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	93530000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	93530000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14963000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14963000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15020000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15020000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1165694000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1177484000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-548273000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-539422000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1119000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2055000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	709832000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	729537000	usd
CY2023Q4	csr	Noncontrolling Interest In Operating Partnerships And Preferred Unit Holders NoncontrollingInterestInOperatingPartnershipsAndPreferredUnitHolders	220544000	usd
CY2022Q4	csr	Noncontrolling Interest In Operating Partnerships And Preferred Unit Holders NoncontrollingInterestInOperatingPartnershipsAndPreferredUnitHolders	220132000	usd
CY2023Q4	csr	Noncontrolling Interest In Consolidated Real Estate Entities NoncontrollingInterestInConsolidatedRealEstateEntities	649000	usd
CY2022Q4	csr	Noncontrolling Interest In Consolidated Real Estate Entities NoncontrollingInterestInConsolidatedRealEstateEntities	627000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	931025000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	950296000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1926361000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2033301000	usd
CY2023	us-gaap	Revenues Revenues	261309000	usd
CY2022	us-gaap	Revenues Revenues	256716000	usd
CY2021	us-gaap	Revenues Revenues	201705000	usd
CY2023	csr	Property Operating Expenses Excluding Real Estate Taxes PropertyOperatingExpensesExcludingRealEstateTaxes	77053000	usd
CY2022	csr	Property Operating Expenses Excluding Real Estate Taxes PropertyOperatingExpensesExcludingRealEstateTaxes	80070000	usd
CY2021	csr	Property Operating Expenses Excluding Real Estate Taxes PropertyOperatingExpensesExcludingRealEstateTaxes	57753000	usd
CY2023	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	28759000	usd
CY2022	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	28567000	usd
CY2021	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	24104000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9353000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9895000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8752000	usd
CY2023	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-2095000	usd
CY2022	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-1591000	usd
CY2021	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-344000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101678000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	105257000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	92165000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	5218000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20080000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17516000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16213000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	244236000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	242896000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	199331000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	71244000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	41000	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	27518000	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-3864000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	84453000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	13861000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	29892000	usd
CY2023	us-gaap	Interest Expense InterestExpense	36429000	usd
CY2022	us-gaap	Interest Expense InterestExpense	32750000	usd
CY2021	us-gaap	Interest Expense InterestExpense	29078000	usd
CY2023	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	1207000	usd
CY2022	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	1248000	usd
CY2021	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	-2915000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-17641000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2101000	usd
CY2021	csr	Preferred Stock Dividends PreferredStockDividends	640000	usd
CY2023	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	125000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6428000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17118000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15216000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13803000	shares
CY2023	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax	1581000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax	2383000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax	-936000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax	-799000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax	-9087000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	50167000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-15261000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9369000	usd
CY2023	csr	Comprehensive Income Attributable To Noncontrolling Interest Operating Partnership And Preferred Unit Holders ComprehensiveIncomeAttributableToNoncontrollingInterestOperatingPartnershipAndPreferredUnitHolders	6985000	usd
CY2022	csr	Comprehensive Income Attributable To Noncontrolling Interest Operating Partnership And Preferred Unit Holders ComprehensiveIncomeAttributableToNoncontrollingInterestOperatingPartnershipAndPreferredUnitHolders	-4708000	usd
CY2021	csr	Comprehensive Income Attributable To Noncontrolling Interest Operating Partnership And Preferred Unit Holders ComprehensiveIncomeAttributableToNoncontrollingInterestOperatingPartnershipAndPreferredUnitHolders	-4407000	usd
CY2023	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	125000	usd
CY2022	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	127000	usd
CY2021	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Nonredeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable	94000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	43057000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10680000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13682000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	672823000	usd
CY2021	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-2741000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	11470000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.84
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	42669000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2689000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	156038000	usd
CY2021	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
CY2021	us-gaap	Temporary Equity Issue Period Increase Or Decrease TemporaryEquityIssuePeriodIncreaseOrDecrease	-8771000	usd
CY2021	us-gaap	Stockholders Equity Other StockholdersEquityOther	1301000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	996280000	usd
CY2022	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-18281000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	2380000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.92
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	47445000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2615000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	31439000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	22882000	usd
CY2022	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
CY2022	csr	Partners Capital Account Cash Redemptions PartnersCapitalAccountCashRedemptions	4141000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	29059000	usd
CY2022	us-gaap	Temporary Equity Issue Period Increase Or Decrease TemporaryEquityIssuePeriodIncreaseOrDecrease	8771000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1284000	usd
CY2022	us-gaap	Stockholders Equity Other StockholdersEquityOther	404000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	950296000	usd
CY2023	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	48591000	usd
CY2023	csr	Amortization Of Swap Settlements AmortizationOfSwapSettlements	936000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.92
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	46442000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	3295000	usd
CY2023	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	11539000	usd
CY2023	us-gaap	Stockholders Equity Other StockholdersEquityOther	928000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	931025000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	49231000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-17641000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2101000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103172000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	106208000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	93110000	usd
CY2023	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	71240000	usd
CY2022	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	41000	usd
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	27518000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3295000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2615000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2689000	usd
CY2023	csr	Impairment Of Real Estate Continuing And Discontinued Operations ImpairmentOfRealEstateContinuingAndDiscontinuedOperations	5218000	usd
CY2022	csr	Impairment Of Real Estate Continuing And Discontinued Operations ImpairmentOfRealEstateContinuingAndDiscontinuedOperations	0	usd
CY2021	csr	Impairment Of Real Estate Continuing And Discontinued Operations ImpairmentOfRealEstateContinuingAndDiscontinuedOperations	0	usd
CY2023	csr	Gain Loss On Derivative Termination Amortization And Mark To Market GainLossOnDerivativeTerminationAmortizationAndMarkToMarket	-936000	usd
CY2022	csr	Gain Loss On Derivative Termination Amortization And Mark To Market GainLossOnDerivativeTerminationAmortizationAndMarkToMarket	118000	usd
CY2021	csr	Gain Loss On Derivative Termination Amortization And Mark To Market GainLossOnDerivativeTerminationAmortizationAndMarkToMarket	-4931000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	340000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1355000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2304000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1436000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	392000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-265000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	760000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	645000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5402000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2108000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	650000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15750000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	89520000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	91991000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	84028000	usd
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	1579000	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	18614000	usd
CY2023	csr	Net Proceeds From Sale Of Real Estate And Other Investments NetProceedsFromSaleOfRealEstateAndOtherInvestments	223259000	usd
CY2022	csr	Net Proceeds From Sale Of Real Estate And Other Investments NetProceedsFromSaleOfRealEstateAndOtherInvestments	41000	usd
CY2021	csr	Net Proceeds From Sale Of Real Estate And Other Investments NetProceedsFromSaleOfRealEstateAndOtherInvestments	61334000	usd
CY2023	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	42226000	usd
CY2022	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	104666000	usd
CY2021	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	273566000	usd
CY2023	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	58825000	usd
CY2022	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	56568000	usd
CY2021	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	31303000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	122000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1264000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	420000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1221000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	3812000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	120209000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-160094000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-267225000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	90000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	196725000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	46749000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28960000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	36282000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	135104000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	191860000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	258580000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	218604000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	154360000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	335451000	usd
CY2023	csr	Proceeds From Repayments Of Notes Payable And Other Debt ProceedsFromRepaymentsOfNotesPayableAndOtherDebt	0	usd
CY2022	csr	Proceeds From Repayments Of Notes Payable And Other Debt ProceedsFromRepaymentsOfNotesPayableAndOtherDebt	99529000	usd
CY2021	csr	Proceeds From Repayments Of Notes Payable And Other Debt ProceedsFromRepaymentsOfNotesPayableAndOtherDebt	174544000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	100000000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	145000000	usd
CY2023	csr	Payments For Termination Of Derivative PaymentsForTerminationOfDerivative	0	usd
CY2022	csr	Payments For Termination Of Derivative PaymentsForTerminationOfDerivative	3209000	usd
CY2021	csr	Payments For Termination Of Derivative PaymentsForTerminationOfDerivative	3804000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31439000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	156038000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11539000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	29059000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	38000	usd
CY2022	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	4141000	usd
CY2021	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	43742000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	44461000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	38487000	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	6428000	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	6428000	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	6428000	usd
CY2023	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	9530000	usd
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	9797000	usd
CY2021	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	4916000	usd
CY2023	csr	Payments Of Ordinary Dividends Preferred Unitholders PaymentsOfOrdinaryDividendsPreferredUnitholders	640000	usd
CY2022	csr	Payments Of Ordinary Dividends Preferred Unitholders PaymentsOfOrdinaryDividendsPreferredUnitholders	640000	usd
CY2021	csr	Payments Of Ordinary Dividends Preferred Unitholders PaymentsOfOrdinaryDividendsPreferredUnitholders	640000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-185000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-404000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-367000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-212351000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41369000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	214512000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2622000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26734000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	31315000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11891000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38625000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7310000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9269000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11891000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38625000	usd
CY2023	csr	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	9747000	usd
CY2022	csr	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	6008000	usd
CY2021	csr	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	5253000	usd
CY2023	csr	Conversion Of Stock Amount Converted Net ConversionOfStockAmountConvertedNet	-1910000	usd
CY2022	csr	Conversion Of Stock Amount Converted Net ConversionOfStockAmountConvertedNet	-1353000	usd
CY2021	csr	Conversion Of Stock Amount Converted Net ConversionOfStockAmountConvertedNet	-4714000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11552000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11625000	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11411000	usd
CY2023	csr	Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes	190000	usd
CY2022	csr	Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes	1284000	usd
CY2021	csr	Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes	933000	usd
CY2023	csr	Gain Loss Relatedto Litigation Settlement Non Cash Portion GainLossRelatedtoLitigationSettlementNonCashPortion	-1000000	usd
CY2022	csr	Gain Loss Relatedto Litigation Settlement Non Cash Portion GainLossRelatedtoLitigationSettlementNonCashPortion	0	usd
CY2021	csr	Gain Loss Relatedto Litigation Settlement Non Cash Portion GainLossRelatedtoLitigationSettlementNonCashPortion	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4224000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	52723000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	41623000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	20000000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	22882000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0	usd
CY2023	csr	Fair Value Adjustment Debt FairValueAdjustmentDebt	-3924000	usd
CY2022	csr	Fair Value Adjustment Debt FairValueAdjustmentDebt	1224000	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2023	csr	Change In Value Of Series D Preferred Units ChangeInValueOfSeriesDPreferredUnits	0	usd
CY2022	csr	Change In Value Of Series D Preferred Units ChangeInValueOfSeriesDPreferredUnits	8771000	usd
CY2021	csr	Change In Value Of Series D Preferred Units ChangeInValueOfSeriesDPreferredUnits	-8771000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	0	usd
CY2022	csr	Noncash Or Part Noncash Acquisition Write Off Of Receivable In Exchange For Property NoncashOrPartNoncashAcquisitionWriteOffOfReceivableInExchangeForProperty	43276000	usd
CY2021	csr	Noncash Or Part Noncash Acquisition Write Off Of Receivable In Exchange For Property NoncashOrPartNoncashAcquisitionWriteOffOfReceivableInExchangeForProperty	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	217513000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	34182000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	31272000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	26528000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8630000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10458000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31267000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	639000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1433000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7358000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9269000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11891000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38625000	usd
CY2023Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	72	apartmentcommunity
CY2023Q4	csr	Interest In Operating Partnership InterestInOperatingPartnership	0.836
CY2022Q4	csr	Interest In Operating Partnership InterestInOperatingPartnership	0.829
CY2022Q4	csr	Percentage Of General Interest Partnership PercentageOfGeneralInterestPartnership	1
CY2023Q4	csr	Percentage Of General Interest Partnership PercentageOfGeneralInterestPartnership	1
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF ESTIMATES</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECLASSIFICATIONS</span></div>Certain previously reported amounts have been reclassified to conform to the current financial statement presentation. These reclassifications had no impact on net income as reported in the Consolidated Statement of Operations, total assets, liabilities or equity as reported in the Consolidated Balance Sheets and the classifications within the Consolidated Statements of Cash Flows. Centerspace reclassified certain items within the disaggregated revenue table included in Note 2.
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1900000000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2000000000	usd
CY2022	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	0	usd
CY2021	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	0	usd
CY2023	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	0	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	5200000	usd
CY2023	csr	Number Of Apartment Communities Impaired During Year NumberOfApartmentCommunitiesImpairedDuringYear	2	apartmentcommunity
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023	csr	Number Of Year After Date Of Acquisition Related To Adjustment Of Real Estate Preliminary Allocations Of Purchase Price NumberOfYearAfterDateOfAcquisitionRelatedToAdjustmentOfRealEstatePreliminaryAllocationsOfPurchasePrice	P1Y
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	1824000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	1769000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	1608000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	1318000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	929000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	5366000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	12814000	usd
CY2023	csr	Number Of Taxable Reit Subsidiaries NumberOfTaxableREITSubsidiaries	1	consolidatedentity
CY2023Q4	us-gaap	Other Assets OtherAssets	27649000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	22687000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2600000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12300000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13500000	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	243931000	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	240031000	usd
CY2021	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	189452000	usd
CY2023	us-gaap	Variable Lease Income VariableLeaseIncome	12433000	usd
CY2022	us-gaap	Variable Lease Income VariableLeaseIncome	10754000	usd
CY2021	us-gaap	Variable Lease Income VariableLeaseIncome	8565000	usd
CY2023	us-gaap	Revenues Revenues	261309000	usd
CY2022	us-gaap	Revenues Revenues	256716000	usd
CY2021	us-gaap	Revenues Revenues	201705000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	71200000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	41000	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	27500000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET CONCENTRATION RISK</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to increased exposure from economic and other competitive factors specific to markets where it holds a significant percentage of the carrying value of its real estate portfolio. As of December 31, 2023, Centerspace held more than 10% of the carrying value of its real estate portfolio in the Minneapolis, Minnesota and Denver, Colorado markets.</span></div>
CY2023	csr	Minimum Dividend Distribution Percentage MinimumDividendDistributionPercentage	0.90
CY2022	csr	Dividend Distribution Percentage DividendDistributionPercentage	0.90
CY2021	csr	Dividend Distribution Percentage DividendDistributionPercentage	0.90
CY2023	csr	Dividend Distribution Percentage DividendDistributionPercentage	0.90
CY2023	csr	Distribution Made Under Capital Gain DistributionMadeUnderCapitalGain	0.4879
CY2022	csr	Distribution Made Under Capital Gain DistributionMadeUnderCapitalGain	0
CY2021	csr	Distribution Made Under Capital Gain DistributionMadeUnderCapitalGain	0.0092
CY2023	csr	Distribution Made Under Federal Income Tax DistributionMadeUnderFederalIncomeTax	0.2846
CY2022	csr	Distribution Made Under Federal Income Tax DistributionMadeUnderFederalIncomeTax	0.1342
CY2021	csr	Distribution Made Under Federal Income Tax DistributionMadeUnderFederalIncomeTax	0.0782
CY2023	csr	Distribution Made As Return Of Capital DistributionMadeAsReturnOfCapital	0.2275
CY2022	csr	Distribution Made As Return Of Capital DistributionMadeAsReturnOfCapital	0.8658
CY2021	csr	Distribution Made As Return Of Capital DistributionMadeAsReturnOfCapital	0.9126
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	347000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	556000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	267000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	217000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	7039000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	5871000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	7828000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	6520000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	5294000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	1954000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2723000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2112000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2798000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3120000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	491000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	866000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	862000	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	1471000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4600000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4900000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1800000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1800000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	3200000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	3200000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2500000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1300000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	1900000	usd
CY2023	csr	Asset Impairment Charges Excluding Insurance Settlement Receivable AssetImpairmentChargesExcludingInsuranceSettlementReceivable	2000000	usd
CY2023	csr	Number Of Apartment Community Assets Subject To Insurance Recoveries NumberOfApartmentCommunityAssetsSubjectToInsuranceRecoveries	3	apartmentcommunity
CY2023Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	1200000	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-3900000	usd
CY2023Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	2900000	usd
CY2023	csr	Ratio Of Units Exchanged For Shares RatioOfUnitsExchangedForShares	1
CY2023	us-gaap	Net Income Loss NetIncomeLoss	41325000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14109000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-29000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6428000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6428000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6428000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	34897000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20537000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6457000	usd
CY2023	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	-4877000	usd
CY2022	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	4299000	usd
CY2021	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	2806000	usd
CY2023	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	0	usd
CY2022	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	640000	usd
CY2021	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	640000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	39774000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24196000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8623000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14994000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15216000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13803000	shares
CY2023	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	24000	shares
CY2022	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
CY2021	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17118000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15216000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13803000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.33
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.35
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.32
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2023Q4	csr	Noncontrolling Interests Operating Partnership Units NoncontrollingInterestsOperatingPartnershipUnits	861000	shares
CY2022Q4	csr	Noncontrolling Interests Operating Partnership Units NoncontrollingInterestsOperatingPartnershipUnits	971000	shares
CY2022	csr	Noncontrolling Interest In Operating Partnership Units Issued NoncontrollingInterestInOperatingPartnershipUnitsIssued	209000	shares
CY2022	csr	Number Of Real Estate Properties Acquired NumberOfRealEstatePropertiesAcquired	3	apartmentcommunity
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15000000	shares
CY2022	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	338000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	The table below provides details on the shares repurchased during the <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">years ended December 31, 2023 and 2022. As of December 31, 2023, the Company had $9.4 million remaining authorized for purchase under this program. </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of Common Shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aggregate Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Price Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year ended December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,539 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year ended December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">432 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.18pt">Amount includes commissions.</span></div>
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	9400000	usd
CY2023Q4	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	649000	usd
CY2022Q4	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	627000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	919990000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0354
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1011777000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0362
CY2023	csr	Debt Instrument Weighted Average Maturity DebtInstrumentWeightedAverageMaturity	P6Y3M18D
CY2023Q4	csr	Number Of Real Estate Properties Collateral NumberOfRealEstatePropertiesCollateral	14	apartmentproperty
CY2022Q4	csr	Number Of Real Estate Properties Collateral NumberOfRealEstatePropertiesCollateral	15	apartmentproperty
CY2023Q4	csr	Number Of Real Estate Properties Unencumbered NumberOfRealEstatePropertiesUnencumbered	46	apartmentproperty
CY2023Q4	csr	Number Of Real Estate Properties Collateral NumberOfRealEstatePropertiesCollateral	14	apartmentproperty
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6860000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	66290000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	99120000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	48666000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	118365000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	580689000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	919990000	usd
CY2023	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	713000	usd
CY2023	us-gaap	Revenues Revenues	261309000	usd
CY2023	csr	Property Operating Expense PropertyOperatingExpense	105812000	usd
CY2023	csr	Net Operating Income Loss NetOperatingIncomeLoss	155497000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9353000	usd
CY2023	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-2095000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101678000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	5218000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20080000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	71244000	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-3864000	usd
CY2023	us-gaap	Interest Expense InterestExpense	36429000	usd
CY2023	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	1207000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	49231000	usd
CY2022	us-gaap	Revenues Revenues	256716000	usd
CY2022	csr	Property Operating Expense PropertyOperatingExpense	108637000	usd
CY2022	csr	Net Operating Income Loss NetOperatingIncomeLoss	148079000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9895000	usd
CY2022	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-1591000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	105257000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17516000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	41000	usd
CY2022	us-gaap	Interest Expense InterestExpense	32750000	usd
CY2022	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	1248000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-17641000	usd
CY2021	us-gaap	Revenues Revenues	201705000	usd
CY2021	csr	Property Operating Expense PropertyOperatingExpense	81857000	usd
CY2021	csr	Net Operating Income Loss NetOperatingIncomeLoss	119848000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8752000	usd
CY2021	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-344000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	92165000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16213000	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	27518000	usd
CY2021	us-gaap	Interest Expense InterestExpense	29078000	usd
CY2021	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	-2915000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-2101000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2420146000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	530703000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1889443000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8630000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	639000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	27649000	usd
CY2023Q4	us-gaap	Assets Assets	1926361000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2534124000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	535401000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1998723000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10458000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1433000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	22687000	usd
CY2022Q4	us-gaap	Assets Assets	2033301000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.050
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1000000	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-3900000	usd
CY2023Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	2900000	usd
CY2023	csr	Redemptionbasis Redemptionbasis	1
CY2023	csr	Number Of Consecutive Trading Days For Valuation NumberOfConsecutiveTradingDaysForValuation	P10D
CY2022	csr	Number Of Consecutive Trading Days For Valuation NumberOfConsecutiveTradingDaysForValuation	P10D
CY2023Q4	csr	Redemption Value Of Upreit Units RedemptionValueOfUpreitUnits	50400000	usd
CY2022Q4	csr	Redemption Value Of Upreit Units RedemptionValueOfUpreitUnits	58000000	usd
CY2023Q4	csr	Number Of Real Estate Technology Venture Funds With Unfunded Commitments NumberOfRealEstateTechnologyVentureFundsWithUnfundedCommitments	2	realestatetechnologyventurefund
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	775000	shares
CY2015Q3	csr	Share Based Compensation Arrangement By Share Based Payment Award Term Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward	P10Y
CY2023	csr	Share Based Compensation Arrangement By Share Based Payment Award Term Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward	P3Y
CY2023Q1	us-gaap	Share Price SharePrice	58.67
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3295000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2615000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2689000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	45955	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	139048	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	66.36
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	43629	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	70.64
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	182677	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	67.38
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	34758	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	66.36
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30245	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	110.67
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16299	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	67.59
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	196623	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	74.02
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	80421	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	66.94
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	45955	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	58.67
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20061	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	58.67
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	103768	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	73.03
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1739	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	80.66
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	117010	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.41
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	59477	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	70.06
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M9D
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2534124000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2271170000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1812557000	usd
CY2023	us-gaap	Real Estate Other Additions RealEstateOtherAdditions	87757000	usd
CY2022	us-gaap	Real Estate Other Additions RealEstateOtherAdditions	206623000	usd
CY2021	us-gaap	Real Estate Other Additions RealEstateOtherAdditions	491648000	usd
CY2023	us-gaap	Real Estate Improvements RealEstateImprovements	62117000	usd
CY2022	us-gaap	Real Estate Improvements RealEstateImprovements	57203000	usd
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	34427000	usd
CY2023	csr	Real Estate Total Additions RealEstateTotalAdditions	2683998000	usd
CY2022	csr	Real Estate Total Additions RealEstateTotalAdditions	2534996000	usd
CY2021	csr	Real Estate Total Additions RealEstateTotalAdditions	2338632000	usd
CY2023	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	243889000	usd
CY2022	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	57698000	usd
CY2023	csr	Real Estate Impairment Charge RealEstateImpairmentCharge	5218000	usd
CY2022	csr	Real Estate Impairment Charge RealEstateImpairmentCharge	0	usd
CY2021	csr	Real Estate Impairment Charge RealEstateImpairmentCharge	0	usd
CY2023	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	14745000	usd
CY2022	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	872000	usd
CY2021	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	9764000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2420146000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2534124000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	2271170000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	535401000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	443592000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	399249000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	98691000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	92056000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	78268000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	92239000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	24161000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	11150000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	247000	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	9764000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	530703000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	535401000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	443592000	usd
CY2023Q4	us-gaap	Investments Investments	1889443000	usd
CY2022Q4	us-gaap	Investments Investments	1998723000	usd
CY2021Q4	us-gaap	Investments Investments	1827578000	usd
CY2023	csr	Number Of Apartment Communities Impaired During Year NumberOfApartmentCommunitiesImpairedDuringYear	2	apartmentcommunity
CY2023Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	1400000000	usd
CY2022Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	1500000000	usd

Files In Submission

Name	View Source	Status
0000798359-24-000019-index-headers.html	Edgar Link	pending
0000798359-24-000019-index.html	Edgar Link	pending
0000798359-24-000019.txt	Edgar Link	pending
0000798359-24-000019-xbrl.zip	Edgar Link	pending
centerspace12312310kex211.htm	Edgar Link	pending
centerspace12312310kex231.htm	Edgar Link	pending
centerspace12312310kex311.htm	Edgar Link	pending
centerspace12312310kex312.htm	Edgar Link	pending
centerspace12312310kex321.htm	Edgar Link	pending
centerspace12312310kex322.htm	Edgar Link	pending
centerspaceinsidertradingp.htm	Edgar Link	pending
csr-20231231.htm	Edgar Link	pending
csr-20231231.xsd	Edgar Link	pending
csr-20231231_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
neoclawbackpolicy.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
csr-20231231_cal.xml	Edgar Link	unprocessable
csr-20231231_def.xml	Edgar Link	unprocessable
csr-20231231_lab.xml	Edgar Link	unprocessable
csr-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
csr-20231231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CSR
Centerspace Stock $csr

2024 Q1 Form 10-K Financial Statement

#000079835924000019 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSR Centerspace Stock $csr

2024 Q1 Form 10-K Financial Statement

#000079835924000019 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSR
Centerspace Stock $csr